Phaser crystallographic software

Abstract

Phaser is a program for phasing macromolecular crystal structures by both molecular replacement and experimental phasing methods. The novel phasing algorithms implemented in Phaser have been developed using maximum likelihood and multivariate statistics. For molecular replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solutions from noise, and for single-wavelength anomalous dispersion experimental phasing, the new algorithms, which account for correlations between F + and F − , give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences Δ F . One of the design concepts of Phaser was that it be capable of a high degree of automation. To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input. Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallographic community.

Cited by papers we hold 366

• De novo designed proteins neutralize lethal snake venom toxins · 2025
  No notice
• Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers · 2024
  Corrected
• Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers · 2024
  No notice
• TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry · 2023
  No notice
• Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 · 2023
  No notice
• Improved cytosine base editors generated from TadA variants · 2023
  No notice
• A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection · 2023
  No notice
• StayGold variants for molecular fusion and membrane-targeting applications · 2023
  No notice
• Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant · 2023
  No notice
• Ubiquitin-like conjugation by bacterial cGAS enhances anti-phage defence · 2023
  No notice
• The CCP 4 suite: integrative software for macromolecular crystallography · 2023
  No notice
• Hallucinating symmetric protein assemblies · 2022
  No notice
• Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer · 2022
  Not checked
• Homologous peptides derived from influenza A, B and C viruses induce variable CD8+ T cell responses with cross‐reactive potential · 2022
  Not checked
• Design of protein-binding proteins from the target structure alone · 2022
  No notice
• Mechanistic insights into the regulation of plant phosphate homeostasis by the rice SPX2 – PHR2 complex · 2022
  Not checked
• Structural analysis of Red1 as a conserved scaffold of the RNA-targeting MTREC/PAXT complex · 2022
  Not checked
• Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies · 2022
  Not checked
• Engineering an autonomous VH domain to modulate intracellular pathways and to interrogate the eIF4F complex · 2022
  Not checked
• Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design · 2022
  Not checked

and 346 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.